Opportunity
Federal Register #2026-09566
DEA Schedules CUMYL-PEGACLONE as Schedule I Controlled Substance; Coast Guard Issues Temporary Event Regulation
Buyer
Drug Enforcement Administration
Posted
May 13, 2026
Identifier
2026-09566
This summary covers a DEA regulatory action and a Coast Guard event regulation: - Government Buyer: - Drug Enforcement Administration (DEA), Department of Justice - OEMs and Vendors: - No OEMs or commercial vendors are involved; this is a regulatory action, not a procurement - Products/Services Requested: - No products or services are being procured - CUMYL-PEGACLONE (5-pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-b]indol-1-one), including its salts, isomers, and salts of isomers, is being placed into Schedule I of the Controlled Substances Act - A temporary special local regulation is established for a high-speed power boat event in Piney Point, MD - Unique or Notable Requirements: - Strict regulatory controls and sanctions on the manufacture, distribution, research, and possession of CUMYL-PEGACLONE - Mandatory DEA registration, security, labeling, quota, inventory, reporting, and compliance with Schedule I requirements for any entity handling the substance - Temporary restriction of access to certain waters during the Piney Point event for safety - No procurement, purchase quantities, or part numbers are specified for acquisition
Description
The Drug Enforcement Administration (DEA) issues a final rule placing CUMYL-PEGACLONE, including its salts, isomers, and salts of isomers, in Schedule I of the Controlled Substances Act. This action is taken to fulfill the United States' obligations under the 1971 Convention on Psychotropic Substances and imposes regulatory controls and sanctions on persons who handle or propose to handle this substance. The rule includes requirements for registration, security, labeling, quota, inventory, reporting, order forms, importation, exportation, and liability related to CUMYL-PEGACLONE. The effective date of this final rule is May 13, 2026.